Stock Market News
Non-executive director Thomas Casdagli steps away from Alliance Pharma
Specialty pharmaceutical firm Alliance Pharma announced on Wednesday that non-executive director Thomas Casdagli will step down from the board with immediate effect.
The AIM-traded firm said that Casdagli, who is also a partner of MVM Life Science Partners LLP, will be ending a nine year tenure on the company's board.
David Cook, Alliance Pharma's chairman, commented: "On behalf of the board, I would like to thank Tom for his very significant contribution to Alliance over the past nine years. We wish him well for the future."
Casdagli, who is a qualified chartered accountant with an MBioch in Molecular and Cellular Biochemistry from Oxford University, is a member of the boards of Onbone Oy and Patient Connect Ltd.
Furthermore, he was previously a director at Xention Pharma, Lombard Medical Technologies plc, Heptares Ltd and Avantium BV.
Thomas Casdagli said: "It has been a pleasure working with Alliance during my tenure on the board. The company has transformed over this period from a UK-focused established products business to a global pharmaceutical company with good organic and acquisitive growth prospects."
As of 1248 BST, Alliance Pharma's shares were up 0.45% at 89.40p.
The AIM-traded firm said that Casdagli, who is also a partner of MVM Life Science Partners LLP, will be ending a nine year tenure on the company's board.
David Cook, Alliance Pharma's chairman, commented: "On behalf of the board, I would like to thank Tom for his very significant contribution to Alliance over the past nine years. We wish him well for the future."
Casdagli, who is a qualified chartered accountant with an MBioch in Molecular and Cellular Biochemistry from Oxford University, is a member of the boards of Onbone Oy and Patient Connect Ltd.
Furthermore, he was previously a director at Xention Pharma, Lombard Medical Technologies plc, Heptares Ltd and Avantium BV.
Thomas Casdagli said: "It has been a pleasure working with Alliance during my tenure on the board. The company has transformed over this period from a UK-focused established products business to a global pharmaceutical company with good organic and acquisitive growth prospects."
As of 1248 BST, Alliance Pharma's shares were up 0.45% at 89.40p.
Related share prices |
---|
Alliance Pharma (APH) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price